SCHEMBL4145822

SCHEMBL4145822

CCOCNCCNCCNC(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.33
MGAM O43451 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33
TP53 P04637 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 1/20 0.31
POLB P06746 1/20 0.31
PAOX Q6QHF9 1/20 0.31
CA3 P07451 1/20 0.31
CA5A P35218 1/20 0.31
CA5B Q9Y2D0 1/20 0.31
USP2 O75604 1/20 0.30
TSHR P16473 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
LMNA P02545 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8699904 0.91 PAOX (0.39) GAAEGLN1TP53CYP2C19ALDH1A1
SCHEMBL31683981 0.80 FFAR3 (0.36) ALDH1A1KDM4EPOLBTSHR
SCHEMBL30547298 0.80 EGLN1 (0.37) EGLN1CYP2D6ALDH1A1KDM4EPOLB
SCHEMBL29202503 0.79 KDM4E (0.34) GAAMGAMSIMGAM2EGLN1
SCHEMBL11078575 0.78
SCHEMBL2240590 0.78 CA3 (0.42) EGLN1TP53CYP2D6CYP2C19ALDH1A1
SCHEMBL29454886 0.77 TSHR (0.39) ALDH1A1TSHRHSD17B10
SCHEMBL19013345 0.76 PAOX (0.50) CYP2D6CYP2C19POLBPAOXCA3
SCHEMBL4774203 0.76 PAOX (0.50) CYP2D6CYP2C19POLBPAOXCA3
SCHEMBL20759820 0.75 FFAR3 (0.39) EGLN1ALDH1A1KDM4EPOLBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150196586-A1 POLYMERIC MOLECULAR RECEPTORS AS PHOSPHATE SEQUESTRANTS GENZYME CORPORATION 2015-07-16 US disclosed
US-8986669-B2 Method for removing phosphate and polymer used therefore GENZYME CORPORATION (US) 2015-03-24 US disclosed
US-20090047233-A1 Method for removing Phosphate and Polymer Used Therefore GENZYME CORPORATION 2009-02-19 US disclosed
EP-1951266-A2 METHOD FOR REMOVING PHOSPHATE AND POLYMER USED THEREFORE Genzyme Corporation (US) 2008-08-06 EP disclosed
WO-2007027566-A2 METHOD FOR REMOVING PHOSPHATE AND POLYMER USED THEREFORE GENZYME CORPORATION (US) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090047233-A1 Method for removing Phosphate and Polymer Used Therefore PHPT1, PNKP, PHYKPL GAA 494/4885MGAM 90/4885SI 119/4885
US-20150196586-A1 POLYMERIC MOLECULAR RECEPTORS AS PHOSPHATE SEQUESTRANTS PHPT1, SLC34A2, SLC34A1 GAA 1192/4885MGAM 713/4885SI 961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.